Sep 02, 09:07
100% of moneycontrol users recommend buying Parenteral Drug.
What's your call on Parenteral Drug today?
Read Investor view
|Company Name||Last Price||%
|Dr Reddys Labs||2995.60||0.48||2995.60||2286.80||51,025.56|
|Dec' 13||Jun' 13||Mar' 13||Dec' 12|
|No Mutual Funds Holding the share|
IFGL Refractories Recommended on May 28th 2014
Recommended price 114.00 | Peak from reco 209.00 83.01%
What are Multi baggers?
Our experts panel will help you to get you those life-changing stocks, tomorrow's bluechips today.
Parenteral Drug is in the Pharmaceuticals sector. The current market capitalisation stands at Rs 84.68 crore.The company has reported a consolidated sales of Rs 77.11 crore and a Net Loss of Rs -20.48 crore for the quarter ended Jun 2014.
The company management includes Manoharlal Gupta - Chairman, Vinod Kumar Gupta - Managing Director, Govind Das Garg - Whole Time Director, Anil Mittal - WholeTime Director & CEO, Satish Chandra Consul - Independent Director, Dharam Pal Khanna - Independent Director, Dilip Kumar Panchaity - Independent Director, Dilip Kumar Sinha - Independent Director.
It is listed on the BSE with a BSE Code of 524689 and the NSE with an NSE Code of PDPL.
Its Registered office is at 340, Laxmi Plaza, Laxmi Industrial Estate,,New Link Road, Mumbai,Maharashtra - 400053.
Their Registrars are Link Intime India Pvt. Ltd.